Amylyx Pharmaceuticals, Inc.
AMLX
Revenue
0.00
▲665.00k▲100.00%
3 Months ChangeAssets
219.68M
▲26.04M▲13.45%
3 Months ChangeLiabilities
18.26M
▼-10.61M▼-36.75%
3 Months ChangeFree Cash Flow
-39.84M
▼-39.28M▼-7064.57%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-17
Form 8-K
ID: 0001193125-24-238572
2024-08-08
Form 10-Q
ID: 0000950170-24-093311
2024-08-08
Form 8-K
ID: 0000950170-24-093304
2024-07-10
Form 8-K
ID: 0001193125-24-177000
2024-06-21
Form 8-K
ID: 0000950170-24-076339
2024-06-06
Form 8-K
ID: 0001193125-24-156050
2024-05-09
Form 10-Q
ID: 0000950170-24-056269
2024-05-09
Form 8-K
ID: 0000950170-24-056254
2024-04-10
Form 8-K
ID: 0001193125-24-091463
2024-04-04
Form 8-K
ID: 0001193125-24-086609